Sanofi and Regeneron get EU approval for Dupixent
European Commission has extended marketing authorisation for Dupixent European Union to include adolescents 12 to 17 years of age…
Author
US FDA finds “significant violations” at India’s Strides plant
The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16
US group says Novartis MS drug price out of line with benefit
The Boston-based Institute for Clinical and Economic Review (ICER), which has been reviewing Mayzent for months, recommended that…